Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2016; 62(3): 9-19


NITRIC OXIDE SYNTHASE ACTIVITY AND ITS CONCENTRATION IN THE TISSUES OF HUMAN THYROID CARCINOMAS

O.V. Kalinichenko, T.M. Myshunina, M.D. Tron’ko

    State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism of AMS of Ukraine», Kyiv
DOI: https://doi.org/10.15407/fz62.03.009

Abstract

The study of the activity of the constitutive form of nitric oxide synthase (cNOS) revealed that in the papillary thyroid carcinomas it corresponded to that detected in unchanged extratumoral tissue, while the enzyme activity in follicular carcinoma was half lesser. At the same time, the activity of inducible nitric oxide synthase (іNOS) was higher in the papillary and follicular carcinomas. Such changes in the enzyme activity were associated with an increase in its level in papillary carcinomas, and with minor changes in follicular carcinomas. In medullary carcinomas the parameters under study corresponded to those in unchanged tissue, and in the papillary carcinoma metastases without changes in enzyme activity of nitric oxide formation, the level of the latter was much higher. Elevated levels of nitric oxide and іNOS activity in papillary thyroid carcinomas did not depend significantly on the aggression characteristics of the latter, being however absent in tumors of T4 category on a background of reduced cNOS activity and less expressed in tumors surrounded by the tissue in the presence of a chronic thyroiditis. Furthermore, in the papillary carcinomas of papillary or follicular structure nitric oxide level did not differ from the normal range, being slightly higher in tumors of solid or heterogeneous structure with presence of solid areas, whereas in carcinomas of papillary-follicular structure it was twice, and in tissue of solidinsular structure three times higher. іNOS hyperactivity was observed in the carcinomas of different structure, except for tumors of solid structure, in the tumor of which enzyme activity was within the normal range, and in tumor of solid-insular structure where it was significantly higher (as well as cNOS activity) compared with tumors of other structure. Nitric oxide generating system is involved in the transformation of thyroid cells and progression of tumor growth, including through apoptosis regulation, as shown by the results of an analysis of data obtained both in the present study and previously. The nature of such involvement in papillary thyroid carcinomas with different histological structure is different.

Keywords: nitric oxide; constitutive and inducible nitric oxide synthase; thyroid carcinoma; apoptosis.

References

  1. Burlaka AP, Sydoryk EP. Radical oxygen species and nitric oxide in tumor process. Kyiv: Naycova Dymka, 2006. [Ukrainian].
  2.  
  3. Poderoso J. The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Arch Biochem Biophys. 2009; 484(2): 214-20. CrossRef PubMed
  4.  
  5. Napoli C, Paolisso G, Casamassimi A, Al-Omran M, Barbieri M, Sommese L, Infante T, Ignarro L. Effects of nitric oxide on cell proliferation. J Amer College of Cardiol. 2013; 62(2): 89-95. CrossRef PubMed
  6.  
  7. Kandor VI. Autoimmune thyroid disease and apoptosis. Probl Endocrinol. 2002; 48(1): 45-8. [Russian].
  8.  
  9. Fortunato R, Ferreira A, Hecht F, Dupuy C, Carvalho D. Sexual dimorphism and thyroid dysfunction: a matter of oxidative stress? J Endocrinol. 2014; 221(2): R31- R40. CrossRef PubMed
  10.  
  11. Bauer J, Frye G, Bahr A, Gieg J, Brofman P. Anti-tumor effects of nitrosylcobalamin against spontaneous tumors in dogs. Invest New Drugs. 2010; 28(5): 694-702. CrossRef PubMed
  12.  
  13. Melisi D, Rosso F, Curcio A, Tortora C, Nieddu M, Marino G, Lettieri M, Grimaldi A, Luongo E, Romano S, Romano M, Boatto G, Abignente E, Barbarisi A, Rimoli M. Galactosyl derivative of N(omega)-nitro-L-arginine: study of antiproliferative activity on human thyroid follicular carcinoma cells. J Cell Physiol. 2009; 221(2): 440-7. CrossRef PubMed
  14.  
  15. Mishunina TM, Kalinichenko OV, Tron'ko MD, Zurnadzhi LYu. Systems for the generation of nitric oxide in the tissues of the thyroid gland with lymphoid infiltration or chronic thyroiditis. J Acad Med Sci Ukraine. 2015; 21(1): 115-21. [Ukrainian].
  16.  
  17. Mishunina TM, Kalinichenko OV, Tron'ko MD, Zurnadzhi LYu. Nitric oxide and enzymes its synthesis in the tissue of the thyroid benign formations. J Acad Med Sci Ukraine. 2015; 21(3): 42-7. [Ukrainian].
  18. Kalinichenko OV, Mishunina TM, Tron’ko MD, Zurnadzhi LYu. Level of nitric oxide and its synthases activity in the thyroid tissues of patients with Graves’ disease. Еndocrin. 2015; 20(3): 582-9. [Ukrainian].
  19.  
  20. Green L, Wagner D, Glogowskietal J. Analysis of nitrate, nitrite, and 15N nitrate in biological fluids. Anal Biochem. 1982; 126(1): 131-8. CrossRef  
  21. Gula NM, Kosyakova GB, Berdyshev AG. Effect of N-sterolethanolamine on the path of NO-synthase generate of nitric oxide in the aorta and heart of rats with diabetes. Ukr Biochem J. 2007; 79(5): 153-8. [Ukrainian].
  22. LoFaro M, Fox B, Whatmore J, Winyard P, Whiteman M. Hydrogen sulfide and nitric oxide interactions in inflammation. Nitric Oxide. 2014; 41: 38-47. CrossRef PubMed
  23.  
  24. Kim K, Kim S, Kim S, Back J, Park M, Kim J. Cyclooxygenase-2 and inducible nitric oxide synthase expression in thyroid neoplasms and their clinicopathological correlation. J Korean Med Sci. 2006; 21(6): 1064-9. CrossRef PubMed PubMedCentral
  25.  
  26. Mardente S, Zicari A, Consorti F, Mari E, Di Vito M, Leopizzi M, Della Rocca C, Antonaci A. Cross-talk between NO and HMGB1 in lymphocytic thyroiditis and papillary thyroid cancer. Oncol Rep. 2010; 24(6): 1455-61. CrossRef PubMed
  27.  
  28. Choe W, Kim S, Hwang T, Lee S. Expression of inducible nitric oxide synthase in thyroid neoplasms: immunohistochemical and molecular analysis. Pathol Int. 2003; 53(7): 434-9. CrossRef PubMed
  29.  
  30. Donckier J, Michel L, Delos M, Havaux X, Van Beneden R. Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2006; 64(6): 703-10. CrossRef PubMed
  31.  
  32. Nose F, Ichikawa T, Fujiwara M, Okayasu I. Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase. Am J Clin Pathol. 2002; 117(4): 546-51. CrossRef PubMed
  33.  
  34. Patel A, Fenton C, Terrell R, Powers PA, Dinauer C, Tuttle RM, Francis GL. Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents. J Endocrinol Invest. 2002; 25(8): 675-83. CrossRef PubMed
  35.  
  36. Kayser L, Francis D, Broholm H. Immunohistochemical localization of inducible and endothelial constitutive nitric oxide synthase in neoplastic and autoimmune thyroid disorders. APMIS. 2000; 108(11): 785-91. CrossRef PubMed
  37.  
  38. Förstermann U., Sessa W. Nitric oxide synthases: regulation and function. Eur Heart J. 2012; 33(7): 829-37. CrossRef PubMed PubMedCentral
  39.  
  40. Yasuoka H, Kodama R, Hirokawa M, Takamura Y, Miyauchi A, Sanke T, Nakamura Y. CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis. BMC Cancer. 2008; 8: 274. CrossRef PubMed PubMedCentral
  41.  
  42. Scarpino S, D'Alena F, Di Napoli A, Ballarini F, Prat M, Ruco L. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. J Pathol. 2003; 199(2):243-50. CrossRef PubMed
  43. Myshunina TM, Kalinichenko ОV, Tron’ko MD, Zurnadzhi LYu. Characteristic of changes mitochondrial membrane permeability of papillary thyroid cancer tissue and thyroid tissue in presence of cancer cells invasion. J Acad Med Sci Ukraine. 2010; 16(5): 5-22. [Ukrainian].
  44.  
  45. Mishunina TM, Kalinichenko OV, Tronko MD., Statsenko OA. Caspase-3 activity in papillary thyroid carcinomas. Exp Oncol. 2010. 32(4): 1-4.
  46.  
  47. Ramsey M, Sharpless N. ROS as a tumor suppressor? Nat Cell Biol 2006; 8: 1213-4. CrossRef PubMed
  48.  
  49. Baraboy VA. Biooxidants. Kyiv: Knyha plus, 2006. [Russian].
  50.  
  51. Mishunina TM. Mechanisms, advantages, and consequences of glycolysis activation in tumoral cells. J Acad Med Sci Ukraine. 2009; 15(3): 1-32. [Ukrainian].
  52.  
  53. Du Z, Wang H, Zhang H, Gao D. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosisfactor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinol. 2007; 148(9): 4352-61. CrossRef PubMed
  54.  
  55. Lundberg J, Weitzberg E. The biological role of nitrate and nitrite: the times they are a-changin'. Nitric Oxide. 2010; 22(2): 61-3. CrossRef PubMed

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.